Seeing patients in person is still the gold standard, but during COVID-19 social distancing, ophthalmologists can do a great deal through telemedicine.
Catch Cleveland Clinic Cole Eye Institute’s experts at booth 7125 at the American Academy of Ophthalmology’s annual meeting to learn about the latest in research and clinical care, from refractive surgery and cross-linking to intraocular tumors.
Hear about Cleveland Clinic’s latest ophthalmology research and treatment insights by attending these presentations at booth 713.
Experts from the Cleveland Clinic Cole Eye Institute will be giving presentations at our booth at the American Academy of Ophthalmology meeting in Chicago in late October. Here’s the schedule.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Join Cleveland Clinic’s Cole Eye Institute experts for insightful presentations and discussions @ booth 5332.
Long-acting drug delivery ocular implants are being studied at Cole Eye Institute as a viable option to replace frequent injections and office visits.
Using minimally invasive glaucoma surgery as an adjunct to cataract surgery safely restores vision and reduces intraocular pressure in patients with pre-existing mild-to-moderate stage glaucoma.
Cleveland Clinic eye surgeon Rishi Singh, MD, is leading a first-of-its-kind international event—Retina World Conference—to support global scientific and clinical exchange on innovations in retina health.
New Cleveland Clinic research shows that serial hepatic USG — paired with confirmatory CT/MRI scans when needed — has high sensitivity and specificity for detecting asymptomatic uveal melanoma metastases.
Cleveland Clinic researchers demonstrate cell-specific responses to extracellular viruses, which may be helpful in uncovering the mechanisms behind determining a cell’s fate.